Clinical Trial Update: A Study to Investigate Efficacy and Safety of KBL697 in Patients with Moderate Plaque Type Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 study of KBL697 in adults with moderate plaque psoriasis has completed, with efficacy and safety results to be reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• KBL697

Snippet

Sponsor: KoBioLabs | Conditions: Psoriatic Plaque | Phase 2 | Status: COMPLETED